The eating disorders medicine cabinet revisited: A clinician's guide to ipecac and laxatives

International Journal of Eating Disorders

Volumn 40, Issue 4, 2007, Pages 360-368

  Steffen, Kristine J ^a,b,c   Mitchell, James E ^a,b   Roerig, James L ^a,b   Lancaster, Kathryn L ^a  

^a NEUROPSYCHIATRIC RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Bulimia nervosa; Eating disorders; Ipecac; Laxatives

Indexed keywords

ACETYLSALICYLIC ACID; AGORAL; ALOE VERA EXTRACT; ANTHRAQUINONE DERIVATIVE; ANTITHROMBOCYTIC AGENT; BILE ACID; BISAC EVAC; BISACODYL; CASCARA SAGRADA; CASTOR OIL; CHOLAC; COLYTE; CORRECTOL; DIOCTO; DOCUSATE CALCIUM; DOCUSATE SODIUM; DOS; EMULSOIL; EQUALACTIN; EX LAX; FIBERALL; FLEET BABYLAX; FLEET LAXATIVE; GARLIC EXTRACT; GENFIBER; GLYCEROL; GOLYTELY; GUAR GUM; HYDROCIL; IPECAC; ISPAGULA; KONDREMUL PLAIN; KONSYL FIBER; LACTULOSE; LAXATIVE; MACROGOL; MACROGOL 3350; MAGNESIUM CITRATE; MAGNESIUM HYDROXIDE; MAGNESIUM SULFATE; METHYLCELLULOSE; MINERAL OIL; MODANE BULK; OCL; PERDIEM FIBER; PHENOLPHTHALEIN; PHILLIPS LIQUI GELS; PHILLIPS MILK OF MAGNESIA; POLYCARBOPHIL; POLYCARBOPHIL CALCIUM; POLYSACCHARIDE; PURGE; REGULOID; RHUBARB EXTRACT; SANI SUPP; SENNA EXTRACT; SENOKOT; SODIUM DIHYDROGEN PHOSPHATE; SYLLACT; UNCLASSIFIED DRUG; UNIFIBER; UNINDEXED DRUG;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL DISEASE; ALBUMINURIA; ASTHMA; BONE DISEASE; BULIMIA; CLINICAL ARTICLE; COLON DISEASE; CONSTIPATION; CONTACT DERMATITIS; DEHYDRATION; DIARRHEA; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG MISUSE; DRUG USE; EATING DISORDER; EDEMA; ELECTROLYTE DISTURBANCE; ENTEROPATHY; FATIGUE; FLATULENCE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HALITOSIS; HEADACHE; HEART ARRHYTHMIA; HEMATOCRIT; HEMATURIA; HUMAN; HYPERMAGNESEMIA; HYPERNATREMIA; HYPERPHOSPHATEMIA; HYPOGLYCEMIA; HYPOKALEMIA; INTESTINAL SPASM; INTESTINE MOTILITY; KIDNEY DISEASE; LACRIMATION; MEDLINE; MYALGIA; NAUSEA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMELANOSIS COLI; REVIEW; SIDE EFFECT; STOMACH SPASM; TISSUE INJURY; VERTIGO; VOMITING; WEIGHT CONTROL;

CATHARTICS; EATING DISORDERS; EMETICS; HUMANS; IPECAC; SELF ADMINISTRATION; SELF MEDICATION;

EID: 34247528994     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.20365     Document Type: Review

References (65)

1. Manno BR, Manno JE. Toxicology of ipecac: A review. Clin Toxicol 1977;10:221-242.
2. Brotman MC, Forbath N, Garfinkel PE, Humphrey JG. Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa. Can Med Assoc J 1981;125:453-454.
3. Bennett HS, Spiro AJ, Pollack MA, Zucker P. Ipecac-induced myopathy simulating dermatomyositis. Neurology 1982;32:91-94.
4. Friedman EJ. Death from ipecac intoxication in a patient with anorexia nervosa. Am J Psychiatry 1984;141:702-703.
5. Palmer EP, Guay AT. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med 1985;313:1457-1459.
6. Friedman AG, Seime RJ, Roberts T, Fremouw WJ. Ipecac abuse: A serious complication in bulimia. Gen Hosp Psychiatry 1987;9:225-228.
7. Vanin JR. Ipecac abuse-danger. J Am Coll Health 1992;40:237-238.
8. Ho PC, Dweik R, Cohen MC. Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion. Clin Cardiol 1998;21:780-783.
9. Pope HG Jr, Hudson JI, Nixon RA, Herridge PL. The epidemiology of ipecac abuse. N Engl J Med 1986;314:245-246.
10. Greenfeld D, Mickley D, Quinlan DM, Roloff P. Ipecac abuse in a sample of eating disordered outpatients. Int J Eat Disord 1993;13:411-414.
11. Mitchell JE, Pomeroy C, Seppala M, Huber M. Diuretic use as a marker for eating problems and affective disorders among women. J Clin Psychiatry 1988;49:267-270.
12. Abraham SF, Beumont PJ. How patients describe bulimia or binge eating. Psychol Med 1982;12:625-635.
13. Cooper PJ, Fairburn CG. Cognitive behaviour therapy for anorexia nervosa: Some preliminary findings. J Psychosom Res 1984;28:493-499.
14. Mitchell JE, Hatsukami D, Eckert ED, Pyle RL. Characteristics of 275 patients with bulimia. Am J Psychiatry 1985;142:482-485.
15. Neims DM, McNeill J, Giles TR, Todd F. Incidence of laxative abuse in community and bulimic populations: A descriptive review. Int J Eat Disord 1995;17:211-228.
16. Phelps L, Andrea R, Rizzo FG, Johnston L, Main CM. Prevalence of self-induced vomiting and laxative/medication abuse among female adolescents: A longitudinal study. Int J Eat Disord 1993;14:375-378.
17. Roerig JL, Mitchell JE, Steffen KJ. New targets in the treatment of anorexia nervosa. Expert Opin Ther Targets 2005;9:135-151.
18. Lacey JH, Gibson E. Does laxative abuse control body weight? A comparative study of purging and vomiting bulimics. Hum Nutr Appl Nutr 1985;39:36-42.
19. Bo-Linn GW, Santa Ana CA, Morawski SG, Fordtran JS. Purging and calorie absorption in bulimic patients and normal women. Ann Intern Med 1983;99:14-17.
20. Vanin JR, Saylor KE. Laxative abuse: A hazardous habit for weight control. J Am Coll Health 1989;37:227-230.
21. Pryor T, Wiederman MW, McGilley B. Laxative abuse among women with eating disorders: An indication of psychopathology? Int J Eat Disord 1996;20:13-18.
22. Wiederman MW, Pryor T. Multi-impulsivity among women with bulimia nervosa. Int J Eat Disord 1996;20:359-365.
23. Favaro A, Santonastaso P. Impulsive and compulsive self-injurious behavior in bulimia nervosa: Prevalence and psychological correlates. J Nerv Ment Dis 1998;186:157-165.
24. Cockerell CJ. A rational approach to the understanding and management of the dysplastic nevus syndrome concept. Pathol Annu 1993;28(Part 1):121-144.
25. Mitchell JE, Boutacoff LI, Hatsukami D, Pyle RL, Eckert ED. Laxative abuse as a variant of bulimia. J Nerv Ment Dis 1986;174:174-176.
26. Cooke WT. Laxative abuse. Clin Gastroenterol 1977;6:659-673.
27. Kim SK, Gerle RD, Rozanski R. Cathartic colitis. AJR Am J Roentgenol 1978;131:1079-1081.
28. Joo JS, Ehrenpreis ED, Gonzalez L, Kaye M, Breno S, Wexner SD, et al. Alterations in colonic anatomy induced by chronic stimulant laxatives: The cathartic colon revisited. J Clin Gastroenterol 1998;26:283-286.
29. Weiss BD, Wood GA. Laxative abuse causing gastrointestinal bleeding. J Fam Pract 1982;15:177-181.
30. Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Lentz R. Electrolyte and other physiological abnormalities in patients with bulimia. Psychol Med 1983;13:273-278.
31. Malik M, Stratton J, Sweeney WB. Rectal prolapse associated with bulimia nervosa: report of seven cases. Dis Colon Rectum 1997;40:1382-1385.
32. Hardman J, Limbird LE, Gilman A, Hardman JG, Limbird, L. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed., August 2001.
33. Wolters K. Drug Facts and Comparisons. Lippincott, Williams & Wilkins, 2006.
34. Gattuso JM, Kamm MA. Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf 1994;10:47-65.
35. McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998;12:491-497.
36. Tooson JD, Gates LK Jr. Bowel preparation before colonoscopy. Choosing the best lavage regimen. Postgrad Med 1996;100:203-204, 207-212, 214.
37. Camilleri M. Motor function in irritable bowel syndrome. Can J Gastroenterol 1999;13(Suppl A):8A-11A.
38. Staiano A. Use of polyethylene glycol solution in functional and organic constipation in children. Ital J Gastroenterol Hepatol 1999;31(Suppl 3):S260-S263.
39. Valverde CR, Tarara RP, Griffey SM, Roberts JA. Spontaneous intestinal adenocarcinoma in geriatric macaques (Macaca sp.). Comp Med 2000;50:540-544.
40. Arezzo A. Prospective randomized trial comparing bowel cleaning preparations for colonoscopy. Surg Laparosc Endosc Percutan Tech 2000;10:215-217.
41. Nurko S. Advances in the management of pediatric constipation. Curr Gastroenterol Rep 2000;2:234-240.
42. Staumont G, Frexinos J, Fioramonti J, Bueno L. Sennosides and human colonic motility. Pharmacology 1988;36(Suppl 1):49-56.
43. de Witte P, Lemli L. The metabolism of anthranoid laxatives. Hepatogastroenterology 1990;37:601-605.
44. Burman LG. [Debatable questions on Clostridium difficile diarrhea]. Lakartidningen 1992;89:196-197(in Swedish).
45. Tzavella K, Riepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE, Muller-Lissner SA. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 1996;8:1207-1211.
46. Izzo AA, Sautebin L, Borrelli F, et al. The role of nitric oxide in aloe-induced diarrhoea in the rat. Eur J Pharmacol 1999;368:43-48.
47. Holzgartner H, Schmidt U, Kuhn U. Comparison of the efficacy and tolerance of a Garlic preparation vs. bezafibrate. Arzneimittelforschung 1992;42:1473-1477.
48. Asero R, Mistrello G, Roncarolo D, Antoniotti PL, Falagiani P. A case of garlic allergy. J Allergy Clin Immunol 1998;101:427-428.
49. Lee TY, Lam TH. Contact dermatitis due to topical treatment with garlic in Hong Kong. Contact Dermatitis 1991;24:193-196.
50. Berthold HK, Sudhop T, von Bergmann K. Effect of garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. JAMA 1998;279:1900-1902.
51. Jung EM, Jung F, Mrowietz C, et al. Influence of garlic powder on cutaneous microcirculation. A randomized placebo-controlled double blind cross-over survey. Adv Ther 2001;18:189-193.
52. Augusti KT. Therapeutic values of onion. (Allium cepa L.) and garlic (Allium sativum L.). Indian J Exp Biol 1996;34:634-640.
53. Agerwal KC. Therapeutic actions of garlic constituents. Med Res Rev 1996;16:111-124.
54. Bordia A, Verma SK, Srivastava KC. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1998;58:257-263.
55. Gruenwald J, Gruenwalt, J. Physician's Desk Reference for Herbal Medicines, 2nd ed. Thomson PDR, Montvale, NJ, 2000.
56. Morris CA, Avorn J. Internet marketing of herbal products. JAMA 2003;290(11):1505-1509.
57. Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med 1988;148:292-296.
58. Bell LP, Hectorne K, Reynolds H, Balm TK, Hunninghake DB. Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA 1989;261:3419-3423.
59. Levin EG, Miller VT, Muesing RA, Stoy DB, Balm TK, LaRosa JC. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med 1990;150:1822-1827.
60. Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001;44:1201-1209.
61. Qureshi T, Melonakos TK. Acute hypermagnesemia after laxative use. Ann Emerg Med 1996;28:552-555.
62. Als-Nielsen B, Gluud LL, Gluud C. Dopaminergic agonists for hepatic encephalopathy. Cochrane Database Syst Rev 2004(4):CD003047.
63. Siegers CP, von Hertzberg-Lottin E, Otte M, Schneider B. Anthranoid laxative abuse - A risk for colorectal cancer? Gut 1993;34:1099-1101.
64. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998;280:1569-1575.
65. Trigazis L, Tennankore D, Vohra S, Katzman DK. The use of herbal remedies by adolescents with eating disorders. Int J Eat Disord 2004;35:223-228.